Literature DB >> 19537221

A qualitative evaluation of racial disparities in glucose control.

Hannah E Shacter1, Judy A Shea, Ehimare Akhabue, Naveen Sablani, Judith A Long.   

Abstract

OBJECTIVE: Type 2 diabetes is more prevalent and severe among African Americans than among Whites. To elucidate barriers to glucose control that are unique to African Americans with poor glucose control we conducted a qualitative study among veterans with diabetes in an academic Veterans Affairs medical center.
METHODS: We enrolled African American and White veterans with diabetes; participants' glucose control was described as well controlled or poorly controlled, and groups were organized on the basis of ethnicity and glucose control. Discussions were conducted by using modified nominal group technique to define factors that aided or hindered glucose control.
RESULTS: Well-controlled groups similarly reported that self-care, health care, and psychosocial factors were important in controlling glucose. Although poorly controlled African Americans cited self-care as important, they also noted difficulty following self-care practices and the interference of psychosocial factors with glucose control. Poorly controlled Whites were similar. Uniquely, poorly controlled African Americans were less likely to report positive healthcare experiences; their barriers were related to poor access and poor relationships with providers.
CONCLUSIONS: Poorly controlled African Americans endorsed healthy self-care behaviors but found it difficult to follow through. Interventions targeting the management of stress, depression, mood, and temptation, as well as improved access to and communication with providers may help these patients better manage their glucose and minimize disparities in diabetes outcomes. (Ethn Dis. 2009; 19:121-127)

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19537221

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  7 in total

1.  Glaucoma medication adherence among African Americans: program development.

Authors:  Laura E Dreer; Christopher A Girkin; Lisa Campbell; Andy Wood; Liyan Gao; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2013-08       Impact factor: 1.973

2.  Study protocol: Using peer support to aid in prevention and treatment in prediabetes (UPSTART).

Authors:  Michele Heisler; Jeffrey Kullgren; Caroline Richardson; Shelley Stoll; Cristina Alvarado Nieves; Deanne Wiley; Tali Sedgwick; Alyce Adams; Monique Hedderson; Eileen Kim; Megan Rao; Julie A Schmittdiel
Journal:  Contemp Clin Trials       Date:  2020-06-01       Impact factor: 2.226

3.  Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL).

Authors:  Laura E Dreer; Cynthia Owsley; Lisa Campbell; Liyan Gao; Andy Wood; Christopher A Girkin
Journal:  Curr Eye Res       Date:  2015-01-27       Impact factor: 2.424

4.  Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial.

Authors:  Judith A Long; Erica C Jahnle; Diane M Richardson; George Loewenstein; Kevin G Volpp
Journal:  Ann Intern Med       Date:  2012-03-20       Impact factor: 25.391

5.  Trust and Glycemic Control in Black Patients With Diabetic Retinopathy: A Pilot Study.

Authors:  Barry W Rovner; Robin J Casten
Journal:  Diabetes Spectr       Date:  2019-05

6.  Why do some people with type 2 diabetes who are using insulin have poor glycaemic control? A qualitative study.

Authors:  Wen Ting Tong; Shireene Ratna Vethakkan; Chirk Jenn Ng
Journal:  BMJ Open       Date:  2015-01-29       Impact factor: 2.692

7.  Effect of Peer Mentors in Diabetes Self-management vs Usual Care on Outcomes in US Veterans With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Judith A Long; Valerie S Ganetsky; Anne Canamucio; Tanisha N Dicks; Michele Heisler; Steven C Marcus
Journal:  JAMA Netw Open       Date:  2020-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.